The lateral flow assays market size has grown strongly in recent years. It will grow from $12.29 billion in 2025 to $13.45 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing demand for rapid diagnostic solutions, expansion of infectious disease testing, widespread use of rapid test kits, growth of decentralized healthcare delivery, rising awareness of early disease detection.
The lateral flow assays market size is expected to see strong growth in the next few years. It will grow to $19.3 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of home-based diagnostics, expansion of digital health integration, growing demand for multiplex testing, rising investments in rapid diagnostic technologies, increasing focus on real-time disease monitoring. Major trends in the forecast period include increasing adoption of rapid point-of-care diagnostics, rising use of multiplex lateral flow assays, growing integration of digital lfa readers, expansion of veterinary and home-based testing, enhanced focus on test sensitivity.
The widespread occurrence of infectious diseases worldwide significantly drives the growth of the lateral flow assay market. In developing nations, the high incidence of infectious diseases such as HIV and malaria, coupled with inadequate healthcare systems and increasing public awareness, is expected to boost the adoption of lateral flow assay testing. The recent COVID-19 pandemic has underscored the necessity for early detection of illnesses, likely propelling market growth. For example, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, indicated that England reported 368 measles cases in 2023, nearly a sevenfold rise from the 53 cases recorded in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the high prevalence of infectious diseases globally will contribute to the expansion of the lateral flow assay market.
Leading companies in the lateral flow assay market are focusing on creating versatile products, such as lateral flow readers, to enable on-the-go testing and gain a competitive advantage. A lateral flow reader is a portable device designed for the quick and qualitative analysis of lateral flow assays, delivering efficient results across various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare firm, launched the Lateral Flow Test for Triaging Stroke Patients. This test, named LVOne, is specifically designed to enhance the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a rapid blood test that enables paramedics to identify strokes caused by large vessel occlusions (LVO) within 15 minutes. This prompt identification is critical for fast-tracking patients to specialized stroke centers, where timely treatment can significantly improve outcomes and reduce long-term disabilities.
In December 2023, the U.S.-based software company Danaher Corporation successfully acquired Abcam plc for an undisclosed sum. This strategic move was intended to fortify Danaher Corporation's portfolio and market standing, bolstering its position in the life sciences and diagnostics sector. Abcam PLC, headquartered in the UK, is recognized for producing, distributing, and selling protein research tools along with universal lateral flow assay kits.
Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics.
North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lateral flow assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the lateral flow assays market by increasing costs of imported membranes, reagents, antibodies, reader components, and plastic consumables used in test kits. Diagnostic laboratories and healthcare providers in North America and Europe are most affected due to dependence on imported assay components, while Asia-Pacific faces cost pressure on kit manufacturing and exports. These tariffs are raising test kit prices and affecting supply continuity. However, they are also encouraging localized reagent production, regional kit assembly, and diversification of supply chains.
The lateral flow assays market research report is one of a series of new reports that provides lateral flow assays market statistics, including lateral flow assays industry global market size, regional shares, competitors with a lateral flow assays market share, detailed lateral flow assays market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow assays industry. This lateral flow assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A lateral flow assay (LFA) consists of four components: a sample pad where the sample is applied, a conjugate pad that combines labeled tags with biorecognition elements, a reaction membrane featuring test and control lines for the interaction between the target antigen and antibody, and an absorbent pad that collects waste.
The primary categories of lateral flow assays include kits and reagents, along with lateral flow readers. Lateral flow readers are instruments designed for reading and analyzing the results obtained from lateral flow tests. Lateral flow assays operate based on techniques such as sandwich assays, competitive assays, and multiplex detection assays. These assays find applications in various fields, including veterinary diagnostics, clinical/point-of-care testing, drug development and quality testing. They are utilized by hospitals and clinics, diagnostic laboratories, home care settings, as well as pharmaceutical and biotechnology companies, among other end users.
The lateral flow assay market consists of the sale of kits, reagents, and assemblies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this lateral flow assay market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lateral flow assays market size is expected to see strong growth in the next few years. It will grow to $19.3 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of home-based diagnostics, expansion of digital health integration, growing demand for multiplex testing, rising investments in rapid diagnostic technologies, increasing focus on real-time disease monitoring. Major trends in the forecast period include increasing adoption of rapid point-of-care diagnostics, rising use of multiplex lateral flow assays, growing integration of digital lfa readers, expansion of veterinary and home-based testing, enhanced focus on test sensitivity.
The widespread occurrence of infectious diseases worldwide significantly drives the growth of the lateral flow assay market. In developing nations, the high incidence of infectious diseases such as HIV and malaria, coupled with inadequate healthcare systems and increasing public awareness, is expected to boost the adoption of lateral flow assay testing. The recent COVID-19 pandemic has underscored the necessity for early detection of illnesses, likely propelling market growth. For example, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, indicated that England reported 368 measles cases in 2023, nearly a sevenfold rise from the 53 cases recorded in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the high prevalence of infectious diseases globally will contribute to the expansion of the lateral flow assay market.
Leading companies in the lateral flow assay market are focusing on creating versatile products, such as lateral flow readers, to enable on-the-go testing and gain a competitive advantage. A lateral flow reader is a portable device designed for the quick and qualitative analysis of lateral flow assays, delivering efficient results across various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare firm, launched the Lateral Flow Test for Triaging Stroke Patients. This test, named LVOne, is specifically designed to enhance the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a rapid blood test that enables paramedics to identify strokes caused by large vessel occlusions (LVO) within 15 minutes. This prompt identification is critical for fast-tracking patients to specialized stroke centers, where timely treatment can significantly improve outcomes and reduce long-term disabilities.
In December 2023, the U.S.-based software company Danaher Corporation successfully acquired Abcam plc for an undisclosed sum. This strategic move was intended to fortify Danaher Corporation's portfolio and market standing, bolstering its position in the life sciences and diagnostics sector. Abcam PLC, headquartered in the UK, is recognized for producing, distributing, and selling protein research tools along with universal lateral flow assay kits.
Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics.
North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lateral flow assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the lateral flow assays market by increasing costs of imported membranes, reagents, antibodies, reader components, and plastic consumables used in test kits. Diagnostic laboratories and healthcare providers in North America and Europe are most affected due to dependence on imported assay components, while Asia-Pacific faces cost pressure on kit manufacturing and exports. These tariffs are raising test kit prices and affecting supply continuity. However, they are also encouraging localized reagent production, regional kit assembly, and diversification of supply chains.
The lateral flow assays market research report is one of a series of new reports that provides lateral flow assays market statistics, including lateral flow assays industry global market size, regional shares, competitors with a lateral flow assays market share, detailed lateral flow assays market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow assays industry. This lateral flow assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A lateral flow assay (LFA) consists of four components: a sample pad where the sample is applied, a conjugate pad that combines labeled tags with biorecognition elements, a reaction membrane featuring test and control lines for the interaction between the target antigen and antibody, and an absorbent pad that collects waste.
The primary categories of lateral flow assays include kits and reagents, along with lateral flow readers. Lateral flow readers are instruments designed for reading and analyzing the results obtained from lateral flow tests. Lateral flow assays operate based on techniques such as sandwich assays, competitive assays, and multiplex detection assays. These assays find applications in various fields, including veterinary diagnostics, clinical/point-of-care testing, drug development and quality testing. They are utilized by hospitals and clinics, diagnostic laboratories, home care settings, as well as pharmaceutical and biotechnology companies, among other end users.
The lateral flow assay market consists of the sale of kits, reagents, and assemblies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this lateral flow assay market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Lateral Flow Assays Market Characteristics
3. Lateral Flow Assays Market Supply Chain Analysis
4. Global Lateral Flow Assays Market Trends and Strategies
5. Lateral Flow Assays Market Analysis of End Use Industries
7. Global Lateral Flow Assays Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Lateral Flow Assays Total Addressable Market (TAM) Analysis for the Market
9. Lateral Flow Assays Market Segmentation
10. Lateral Flow Assays Market Regional and Country Analysis
11. Asia-Pacific Lateral Flow Assays Market
12. China Lateral Flow Assays Market
13. India Lateral Flow Assays Market
14. Japan Lateral Flow Assays Market
15. Australia Lateral Flow Assays Market
16. Indonesia Lateral Flow Assays Market
17. South Korea Lateral Flow Assays Market
18. Taiwan Lateral Flow Assays Market
19. South East Asia Lateral Flow Assays Market
20. Western Europe Lateral Flow Assays Market
21. UK Lateral Flow Assays Market
22. Germany Lateral Flow Assays Market
23. France Lateral Flow Assays Market
24. Italy Lateral Flow Assays Market
25. Spain Lateral Flow Assays Market
26. Eastern Europe Lateral Flow Assays Market
27. Russia Lateral Flow Assays Market
28. North America Lateral Flow Assays Market
29. USA Lateral Flow Assays Market
30. Canada Lateral Flow Assays Market
31. South America Lateral Flow Assays Market
32. Brazil Lateral Flow Assays Market
33. Middle East Lateral Flow Assays Market
34. Africa Lateral Flow Assays Market
36. Lateral Flow Assays Market Competitive Landscape and Company Profiles
37. Lateral Flow Assays Market Other Major and Innovative Companies
40. Lateral Flow Assays Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Lateral Flow Assays Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lateral flow assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lateral flow assays? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lateral flow assays market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Kits And Reagents; Lateral Flow Readers2) By Technique: Sandwich Assays; Competitive Assays; Multiplex Detection Assays
3) By Application: Veterinary Diagnostics; Clinical Or Point-Of-Care Testing; Drug Development And Quality Testing; Other Applications
4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Home Care Settings; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Kits And Reagents: Rapid Test Kits; Diagnostic Kits; Control Reagents; Sample Collection And Preparation Reagents2) By Lateral Flow Readers: Portable Lateral Flow Readers; Benchtop Lateral Flow Readers; Smartphone-Based Lateral Flow Readers; Automated Lateral Flow Readers
Companies Mentioned: Siemens AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA; Hologic Inc.; BioMérieux SA; PerkinElmer Inc.; Quidel Corporation; Bio-Rad Laboratories Inc.; Roche Holding AG; QIAGEN N.V.; OraSure Technologies Inc.; Meridian Bioscience Inc.; DiaSorin S.p.A.; Molbio Diagnostics; Trinity Biotech; Chembio Diagnostics Inc.; Coris BioConcept; HYCOR Biomedical; Diagnostic BioSystems GmbH; Express Diagnostics Ltd.; Fujirebio Diagnostics Inc.; Innova Diagnostics Inc.; Leadtec Diagnostics Inc.; S&D Diagnostics Inc.; Standard Diagnostics Inc.; V-Chek Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Lateral Flow Assays market report include:- Siemens AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Merck KGaA
- Hologic Inc.
- BioMérieux SA
- PerkinElmer Inc.
- Quidel Corporation
- Bio-Rad Laboratories Inc.
- Roche Holding AG
- QIAGEN N.V.
- OraSure Technologies Inc.
- Meridian Bioscience Inc.
- DiaSorin S.p.A.
- Molbio Diagnostics
- Trinity Biotech
- Chembio Diagnostics Inc.
- Coris BioConcept
- HYCOR Biomedical
- Diagnostic BioSystems GmbH
- Express Diagnostics Ltd.
- Fujirebio Diagnostics Inc.
- Innova Diagnostics Inc.
- Leadtec Diagnostics Inc.
- S&D Diagnostics Inc.
- Standard Diagnostics Inc.
- V-Chek Diagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 13.45 Billion |
| Forecasted Market Value ( USD | $ 19.3 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
